当前位置: X-MOL 学术Theranostics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
Theranostics ( IF 12.4 ) Pub Date : 2018-02-12 , DOI: 10.7150/thno.22010
Xiangchun Li 1, 2 , Weiqi Xu 1 , Wei Kang 3 , Sunny H Wong 1 , Mengyao Wang 4 , Yong Zhou 4 , Xiaodong Fang 4 , Xiuqing Zhang 4 , Huanming Yang 4, 5 , Chi H Wong 6 , Ka F To 3 , Stephen L Chan 6 , Matthew T V Chan 7 , Joseph J Y Sung 1 , William K K Wu 1, 7 , Jun Yu 1
Affiliation  

Objective: Hepatocellular carcinoma (HCC) is a highly heterogeneous disease with a dismal prognosis. However, driver genes and prognostic markers in HCC remain to be identified. It is hoped that in-depth analysis of HCC genomes in relation to available clinicopathological information will give rise to novel molecular prognostic markers.

中文翻译:

肝癌的基因组分析揭示了新的驱动基因和独特的预后特征

目的:肝细胞癌(HCC)是一种高度异质性的疾病,预后不佳。然而,HCC 的驱动基因和预后标记仍有待确定。希望根据现有的临床病理学信息对 HCC 基因组进行深入分析将产生新的分子预后标记。
更新日期:2018-06-01
down
wechat
bug